Ishita Drugs & Industries Share Price

BSE
ISHITADR •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Ishita Drugs & Industries
Ishita Drugs & Industries Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Ishita Drugs & Industries Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
25.02% Fall from 52W High
-12.5
Dividend yield 1yr %
0

Ishita Drugs & Industries shareholding Pattern

Promoter
49.8%
Public
50.1%
Promoter
49.8%
Public
50.2%
Promoter
49.8%
Public
50.2%
Promoter
49.4%
Public
50.6%
Promoter
49.4%
Public
50.6%
Promoter
49.4%
Public
50.6%

Ishita Drugs & Industries Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
9
Bearish Moving Averages
7
5Day EMA
77.70
10Day EMA
77.50
12Day EMA
77.50
20Day EMA
77.70
26Day EMA
78.00
50Day EMA
79.40
100Day EMA
80.50
200Day EMA
79.10
5Day SMA
77.90
10Day SMA
77.50
20Day SMA
77.20
30Day SMA
77.00
50Day SMA
79.50
100Day SMA
82.70
150Day SMA
81.80
200Day SMA
79.40
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
1197 Rs
1348 Rs
Week Rs
705 Rs
848 Rs
Month Rs
702 Rs
862 Rs
Resistance & Support
78.15
Pivot
Resistance
First Resistance
79.19
Second Resistance
79.85
Third Resistance
80.89
Support
First Support
77.49
Second support
76.45
Third Support
75.79
Relative Strength Index
50.73
Money Flow Index
63.51
MACD
-0.44
MACD Signal
-0.73
Average True Range
5.60
Average Directional Index
14.02
Rate of Change (21)
-1.18
Rate of Change (125)
0.49

Ishita Drugs & Industries Company background

Founded in: 1992
Managing director: Jagdish Agrawal
Ishita Drugs Industries Limited was incorporated in Feb.92 by Jagdish Agarwal. The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient. It has a stateofart manufacturing facility, in terms of reaction capabilities, quality control and environmental safety. The plant has been designed and constructed to meet GMP norms.The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad. Buoyed by the growth of its first Venture, the Group made its maiden foray in the pharma sector in 1981 by setting up a small Bulk drugs plant at Surendranagar in Gujarat, to cater to the need of Pharma industry for Quality Products. The Bulk Drugs Industry at that point of time was highly dependent on costly imports and the growth was not achievable. The Company gradually formed a vertically integrated industry chain covering Drug Intermediates, Active Pharma Ingredients (APIs), excipients and finished dosage forms. The Group has 3 manufacturing facilities located in Gujarat, 2 for APIs and drug intermediates (at Ahmedabad and Surendranagar) and 1 for finished pharmaceutical formulations (at Mehsana).Thereafter, the Company set up a project to manufacture bulk drugs at Sanand, in the Ahmedabad district of Gujarat with an installed capacity of 408 tpa. Commercial production commenced in Jan.95. It established an inhouse RD laboratory which has developed a highly improved process technology for norfloxacin, which was implemented in the plant during Oct.95.The Company in 2009 undertook a small expansion cumdebottlenecking project it upgraded many existing equipments.
Read More

Ishita Drugs & Industries FAQs

You can easily buy Ishita Drugs & Industries shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Ishita Drugs & Industries stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -